|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization (accretion) of investments purchased at a premium (discount) | |||||
| Provision for (recovery of) credit losses | |||||
| Asset impairment | |||||
| Non-cash interest expense | |||||
| Loss on partial settlement of convertibles notes | |||||
| Deemed repayment of convertible notes attributable to accreted debt discount | |||||
| Gain on settlement of debt securities | |||||
| Benefit from lease termination | |||||
| Change in fair value of debt securities | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued and other liabilities | |||||
| Warranty obligations | |||||
| Deferred revenues | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of marketable securities | |||||
| Maturities and sales of marketable securities | |||||
| Purchases of property and equipment | |||||
| Purchase of intangible asset | |||||
| Redemption of investment in private companies | |||||
| Business acquisitions, net of cash acquired | |||||
| Investment in debt securities | |||||
| Investment in equity of private company | |||||
| Investment in tax equity fund | |||||
| Issuances of loan receivables | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Issuance of convertible notes, net of issuance costs | |||||
| Purchase of convertible note hedges | |||||
| Sale of warrants | |||||
| Settlement of Notes due 2025 | |||||
| Partial repurchase of convertible notes | |||||
| Proceeds from issuances of common stock under employee equity plans | |||||
| Payments of withholding taxes related to net share settlement of equity awards | |||||
| Repurchases of common stock | |||||
| Payment of excise tax on net stock repurchases | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash — Beginning of period | |||||
| Cash, cash equivalents and restricted cash — End of period | |||||
| Supplemental cash flow disclosure: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing activities: | |||||
| Purchases of property and equipment through tenant improvement allowance | |||||
| Contingent consideration in connection with the acquisition | |||||
| Purchases of property and equipment included in accounts payable | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...